Ronald J. Oudiz

17.3k total citations · 8 hit papers
127 papers, 11.7k citations indexed

About

Ronald J. Oudiz is a scholar working on Pulmonary and Respiratory Medicine, Cardiology and Cardiovascular Medicine and Genetics. According to data from OpenAlex, Ronald J. Oudiz has authored 127 papers receiving a total of 11.7k indexed citations (citations by other indexed papers that have themselves been cited), including 104 papers in Pulmonary and Respiratory Medicine, 66 papers in Cardiology and Cardiovascular Medicine and 21 papers in Genetics. Recurrent topics in Ronald J. Oudiz's work include Pulmonary Hypertension Research and Treatments (102 papers), Cardiovascular Issues in Pregnancy (27 papers) and Cardiovascular Function and Risk Factors (25 papers). Ronald J. Oudiz is often cited by papers focused on Pulmonary Hypertension Research and Treatments (102 papers), Cardiovascular Issues in Pregnancy (27 papers) and Cardiovascular Function and Risk Factors (25 papers). Ronald J. Oudiz collaborates with scholars based in United States, Germany and Italy. Ronald J. Oudiz's co-authors include Adaani Frost, Lewis J. Rubin, Robyn J. Barst, Vallerie V. McLaughlin, David B. Badesch, Nazzareno Galiè, Robert Naeije, Karlman Wasserman, James E. Hansen and Xing‐Guo Sun and has published in prestigious journals such as New England Journal of Medicine, Circulation and Journal of the American College of Cardiology.

In The Last Decade

Ronald J. Oudiz

123 papers receiving 11.4k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Continuous Subcutaneous Infusion of Treprostinil, a Prostacyclin Analogue, in Patients with Pulmonary Arterial Hypertension: A Double-blind, Randomized, Placebo-controlled Trial

2002 1.1k citations Gérald Simonneau, Robyn J. Barst et al. American Journal of Respiratory and Critical Care Medicine profile →
Diagnosis and Assessment of Pulmonary Arterial Hypertension

2009 832 citations David B. Badesch, Marius M. Hoeper et al. Journal of the American College of Cardiology profile →
Ambrisentan for the Treatment of Pulmonary Arterial Hypertension

2008 785 citations Nazzareno Galiè, Horst Olschewski et al. Circulation profile →
Initial Use of Ambrisentan plus Tadalafil in Pulmonary Arterial Hypertension

2015 750 citations Nazzareno Galiè, Joan Albert Barberà et al. New England Journal of Medicine profile →
Right Heart Adaptation to Pulmonary Arterial Hypertension

2013 706 citations Anton Vonk Noordegraaf, François Haddad et al. Journal of the American College of Cardiology profile →
Sitaxsentan Therapy for Pulmonary Arterial Hypertension

2003 540 citations Robyn J. Barst, David Langleben et al. American Journal of Respiratory and Critical Care Medicine profile →
Randomized Study of Adding Inhaled Iloprost to Existing Bosentan in Pulmonary Arterial Hypertension

2006 454 citations Vallerie V. McLaughlin, Ronald J. Oudiz et al. American Journal of Respiratory and Critical Care Medicine profile →
Diagnosis of pulmonary hypertension

2018 297 citations Adaani Frost, David B. Badesch et al. European Respiratory Journal profile →

Peers

Countries citing papers authored by Ronald J. Oudiz

Since Specialization

Citations

This map shows the geographic impact of Ronald J. Oudiz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ronald J. Oudiz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ronald J. Oudiz more than expected).

Fields of papers citing papers by Ronald J. Oudiz

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ronald J. Oudiz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ronald J. Oudiz. The network helps show where Ronald J. Oudiz may publish in the future.

Co-authorship network of co-authors of Ronald J. Oudiz

This figure shows the co-authorship network connecting the top 25 collaborators of Ronald J. Oudiz. A scholar is included among the top collaborators of Ronald J. Oudiz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ronald J. Oudiz. Ronald J. Oudiz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Randomized, Multicenter Study to Assess the Effects of Different Doses of Sildenafil on Mortality in Adults With Pulmonary Arterial Hypertension 2024 ·Circulation ·Marius M. Hoeper, Ralf Ewert, Pavel Jansa, Yu.M. Sіrenko, Andris Skride, Cecile C. Balagtas, (unknown), Susanne Vogt, Paula Abreu, Scott Haughie, Tarek A. Hassan, Ronald J. Oudiz	7
2	The heart of the matter: Right heart imaging indicators for treatment escalation in pulmonary arterial hypertension 2023 ·Pulmonary Circulation ·Paul R. Forfia, Raymond L. Benza, Michele D’Alto, Teresa De Marco, Jean Elwing, Robert P. Frantz, François Haddad, Ronald J. Oudiz, Ioana R. Preston, Stephan Rosenkranz, John Ryan, Robert Schilz, Oksana A. Shlobin, Jean‐Luc Vachiéry, Carmine Dario Vizza, Anton Vonk Noordegraaf, (unknown), Meredith Broderick, Vallerie V. McLaughlin	3
3	Characteristics of patients with pulmonary arterial hypertension from an innovative, comprehensive real‐world patient data repository 2023 ·Pulmonary Circulation ·Harrison W. Farber, Murali M. Chakinala, Michelle Cho, Robert P. Frantz, (unknown), Lisa Lancaster, Scott Milligan, Ronald J. Oudiz, Sumeet Panjabi, Yuen Tsang, Steven D. Nathan	3
4	Parenteral treprostinil induction for rapid attainment of therapeutic doses of oral treprostinil 2023 ·Respiratory Medicine ·(unknown), Verónica Franco, (unknown), Vijay Balasubramanian, (unknown), Ronald Zolty, (unknown), Jessica Huston, Jean Elwing, Ashwin Ravichandran, (unknown), Eric Shen, (unknown), (unknown), Meredith Broderick, Ronald J. Oudiz	3
5	Care of patients with pulmonary arterial hypertension during the coronavirus (COVID‐19) pandemic 2020 ·Pulmonary Circulation ·John Ryan, (unknown), Roham T. Zamanian, Ronald J. Oudiz, Murali M. Chakinala, Erika B. Rosenzweig, Mardi Gomberg‐Maitland	48
6	Author rebuttal to response regarding “Letter to the Editor regarding ‘Could pulmonary arterial hypertension patients be at lower risk from severe COVID‐19?’” 2020 ·Pulmonary Circulation ·Evelyn M. Horn, Murali M. Chakinala, Ronald J. Oudiz, Elizabeth Joseloff, Erika B. Rosenzweig	4
7	Could pulmonary arterial hypertension patients be at a lower risk from severe COVID‐19? 2020 ·Pulmonary Circulation ·Evelyn M. Horn, Murali M. Chakinala, Ronald J. Oudiz, Elizabeth Joseloff, Erika B. Rosenzweig	45
8	Clinical outcomes stratified by baseline functional class after initial combination therapy for pulmonary arterial hypertension 2019 ·Respiratory Research ·R. James White, Anton Vonk Noordegraaf, Stephan Rosenkranz, Ronald J. Oudiz, Vallerie V. McLaughlin, Marius M. Hoeper, Ekkehard Grünig, Hossein Ardeschir Ghofrani, Murali M. Chakinala, Joan Albert Barberà, Christiana Blair, Jonathan Langley, Adaani Frost	17
9	Initial Use of Ambrisentan plus Tadalafil in Pulmonary Arterial Hypertension breakdown → 2015 ·New England Journal of Medicine ·Nazzareno Galiè, Joan Albert Barberà, Adaani Frost, Hossein Ardeschir Ghofrani, Marius M. Hoeper, Vallerie V. McLaughlin, Andrew J. Peacock, Gérald Simonneau, Jean‐Luc Vachiéry, Ekkehard Grünig, Ronald J. Oudiz, Anton Vonk Noordegraaf, R. James White, Christiana Blair, Hunter Gillies, Karen Miller, Julia Harris, Jonathan Langley, Lewis J. Rubin	750
10	Riociguat for Patients With Pulmonary Hypertension Caused by Systolic Left Ventricular Dysfunction 2013 ·Circulation ·Diana Bonderman, Stefano Ghio, Stephan B. Felix, Hossein Ardeschir Ghofrani, Evangelos D. Michelakis, Veselin Mitrović, Ronald J. Oudiz, Francis Boateng, (unknown), Lothar Roessig, Marc J. Semigran	241
11	Right Heart Adaptation to Pulmonary Arterial Hypertension breakdown → 2013 ·Journal of the American College of Cardiology ·Anton Vonk Noordegraaf, François Haddad, Kelly Chin, Paul R. Forfia, Steven M. Kawut, Joost Lumens, Robert Naeije, John H. Newman, Ronald J. Oudiz, S. Provencher, Adam Torbicki, Norbert F. Voelkel, Paul M. Hassoun	706
12	Left Ventricular Systolic Dysfunction Associated with Pulmonary Hypertension Riociguat Trial (LEPHT): Rationale and Design 2012 ·European Journal of Heart Failure ·Stefano Ghio, Diana Bonderman, Stephan B. Felix, Hossein Ardeschir Ghofrani, Evangelos D. Michelakis, Veselin Mitrović, Ronald J. Oudiz, Reiner Frey, Lothar Roessig, Marc J. Semigran	21
13	Tadalafil in idiopathic or heritable pulmonary arterial hypertension compared to pulmonary arterial hypertension associated with connective tissue disease 2011 ·European Respiratory Journal ·Nazzareno Galiè, Robyn J. Barst, Bruce H. Brundage, Hossein Ardeschir Ghofrani, Ronald J. Oudiz, Gérald Simonneau	1
14	The pulmonary arterial hypertension quality enhancement research initiative: comparison of patients with idiopathic PAH to patients with systemic sclerosis-associated PAH 2011 ·Annals of the Rheumatic Diseases ·Philip J. Clements, Mary Tan, Vallerie V. McLaughlin, Ronald J. Oudiz, Victor F. Tapson, Richard N. Channick, Lewis J. Rubin, Anatoly Langer	54
15	Contemporary Trends in the Diagnosis and Management of PAH: An Initiative To Close the Care Gap 2010 ·CHEST Journal ·Vallerie V. McLaughlin, Anatoly Langer, (unknown), Amparo Casanova, Mary Tan, Philip J. Clements, Ronald J. Oudiz, Victor F. Tapson, Richard N. Channick, Lewis J. Rubin	2
16	LONG-TERM IMPROVEMENTS IN CLINICAL WORSENING WITH TADALAFIL IN PATIENTS WITH PULMONARY ARTERIAL HYPERTENSION 2009 ·CHEST Journal ·Ronald J. Oudiz, Carl Arneson, Michael S. Wade	1
17	Ambrisentan for the Treatment of Pulmonary Arterial Hypertension breakdown → 2008 ·Circulation ·Nazzareno Galiè, Horst Olschewski, Ronald J. Oudiz, Ferràn Torres, Adaani Frost, Hossein Ardeschir Ghofrani, David B. Badesch, Michael D. McGoon, Vallerie V. McLaughlin, Ellen B. Roecker, Michael J. Gerber, Christopher Dufton, Brian L. Wiens, Lewis J. Rubin	785
18	Effect of Sildenafil on Ventilatory Efficiency and Exercise Tolerance in Pulmonary Hypertension 2007 ·European Journal of Heart Failure ·Ronald J. Oudiz, (unknown), James E. Hansen, Xing‐Guo Sun, Karlman Wasserman	52
19	Sitaxsentan Therapy for Pulmonary Arterial Hypertension breakdown → 2003 ·American Journal of Respiratory and Critical Care Medicine ·Robyn J. Barst, David Langleben, Adaani Frost, Evelyn M. Horn, Ronald J. Oudiz, Shelley Shapiro, Vallerie V. McLaughlin, Nicholas S. Hill, Victor F. Tapson, Ivan M. Robbins, Diane Zwicke, Benjamin Duncan, Richard A. F. Dixon, Lyn R. Frumkin	540
20	Efficacy and Safety of Treprostinil: An Epoprostenol Analog for Primary Pulmonary Hypertension 2003 ·Journal of Cardiovascular Pharmacology ·Vallerie V. McLaughlin, Seán Gaine, Robyn J. Barst, Ronald J. Oudiz, Robert C. Bourge, Adaani Frost, Ivan M. Robbins, Victor F. Tapson, Michael D. McGoon, David B. Badesch, (unknown), R.F. Roscigno, (unknown), Carl Arneson, Lewis J. Rubin, Stuart Rich	176

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact